Skip to Content

b 861 150 (Flecainide Acetate 150 mg)

Pill with imprint b 861 150 is White, Elliptical / Oval and has been identified as Flecainide Acetate 150 mg. It is supplied by Teva Pharmaceuticals USA.

Flecainide is used in the treatment of atrial fibrillation; atrial flutter; supraventricular tachycardia; wolff-parkinson-white syndrome; paroxysmal supraventricular tachycardia (and more), and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Flecainide 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for b 861 150

Flecainide Acetate

Imprint:
b 861 150
Strength:
150 mg
Color:
White
Size:
14.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
corn starch
sodium stearyl fumarate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide